2020

Vertically integrated by founding Welkin Biotechnology (Wuxi) Co., Ltd., commissioning a16,000 ㎡ facility.
Learn more

2022

Acquired 43 mu of industrial land in the Xinwu District. Secured strategic financing fromWuxi Venture Capital Co., Ltd. to accelerate growth.
Learn more

2022

Achieved a record RMB 423 million in annual sales.
Learn more

2024

Commissioned a new GMP-compliant manufacturing campus in November 2024, totaling48,000 ㎡.
Learn more

2025

The company expands its operations into West Asia and Europe, securing its first Italian client and a multi-million-dollar water treatment systems project, as well as winning a 10-ton large-volume intravenous solution compounding and water purification equipment project in Uzbekistan.
Learn more

Welkin Delivers the First Modular mRNA Formulation and Filling Production Line to a Renowned Domestic Vaccine Manufacturer

(Wuxi, March 10, 2024) Welkin Industry System Engineering Co.,Ltd. recently successfully delivered the core formulation and aseptic filling modules for an mRNA vaccine production line to a leading domestic vaccine manufacturer. The project features a highly integrated skid-mounted design that combines ultra-clean fluid control with fully automated SIP (in-line sterilization) technology, reducing the traditional on-site construction timeline by 40% and enabling the company to rapidly achieve scalable, compliant production of next-generation vaccines. This milestone marks a critical breakthrough for domestically produced high-end biopharmaceutical equipment in the areas of flexibility and intelligence.
Learn more
< 123 >